288 related articles for article (PubMed ID: 25079790)
21. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
[TBL] [Abstract][Full Text] [Related]
22. Metacytofilin Is a Potent Therapeutic Drug Candidate for Toxoplasmosis.
Leesombun A; Iijima M; Umeda K; Kondoh D; Pagmadulam B; Abdou AM; Suzuki Y; Ohba SI; Isshiki K; Kimura T; Kubota Y; Sawa R; Nihei CI; Nishikawa Y
J Infect Dis; 2020 Feb; 221(5):766-774. PubMed ID: 31573038
[TBL] [Abstract][Full Text] [Related]
23. Targeting
Palencia A; Bougdour A; Brenier-Pinchart MP; Touquet B; Bertini RL; Sensi C; Gay G; Vollaire J; Josserand V; Easom E; Freund YR; Pelloux H; Rosenthal PJ; Cusack S; Hakimi MA
EMBO Mol Med; 2017 Mar; 9(3):385-394. PubMed ID: 28148555
[No Abstract] [Full Text] [Related]
24. Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.
Kortagere S; Mui E; McLeod R; Welsh WJ
J Comput Aided Mol Des; 2011 May; 25(5):403-11. PubMed ID: 21359560
[TBL] [Abstract][Full Text] [Related]
25. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
26. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle.
D'Angelo JG; Bordón C; Posner GH; Yolken R; Jones-Brando L
J Antimicrob Chemother; 2009 Jan; 63(1):146-50. PubMed ID: 18988681
[TBL] [Abstract][Full Text] [Related]
27. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
Murata Y; Sugi T; Weiss LM; Kato K
PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
[TBL] [Abstract][Full Text] [Related]
28. Great efficacy of sulfachloropyrazine-sodium against acute murine toxoplasmosis.
Zeng YB; Zhu SH; Dong H; Han HY; Jiang LL; Wang Q; Cheng J; Zhao QP; Ma WJ; Huang B
Asian Pac J Trop Biomed; 2012 Jan; 2(1):70-5. PubMed ID: 23569838
[TBL] [Abstract][Full Text] [Related]
29. Synergistic Activity between Statins and Bisphosphonates against Acute Experimental Toxoplasmosis.
Li ZH; Li C; Szajnman SH; Rodriguez JB; Moreno SNJ
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559264
[TBL] [Abstract][Full Text] [Related]
30. Host cells participate in the in vitro effects of novel diamidine analogues against tachyzoites of the intracellular apicomplexan parasites Neospora caninum and Toxoplasma gondii.
Leepin A; Stüdli A; Brun R; Stephens CE; Boykin DW; Hemphill A
Antimicrob Agents Chemother; 2008 Jun; 52(6):1999-2008. PubMed ID: 18362190
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii.
Romand S; Della Bruna C; Farinotti R; Derouin F
Antimicrob Agents Chemother; 1996 Sep; 40(9):2015-20. PubMed ID: 8878573
[TBL] [Abstract][Full Text] [Related]
32. Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity.
Neville AJ; Zach SJ; Wang X; Larson JJ; Judge AK; Davis LA; Vennerstrom JL; Davis PH
Antimicrob Agents Chemother; 2015 Dec; 59(12):7161-9. PubMed ID: 26392504
[TBL] [Abstract][Full Text] [Related]
33. Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo.
de Oliveira TC; Silva DA; Rostkowska C; Béla SR; Ferro EA; Magalhães PM; Mineo JR
Exp Parasitol; 2009 Jul; 122(3):233-41. PubMed ID: 19389400
[TBL] [Abstract][Full Text] [Related]
34. Sterculic Acid and Its Analogues Are Potent Inhibitors of Toxoplasma gondii.
Hao P; Alaraj IQ; Dulayymi JR; Baird MS; Liu J; Liu Q
Korean J Parasitol; 2016 Apr; 54(2):139-45. PubMed ID: 27180571
[TBL] [Abstract][Full Text] [Related]
35. Phytochemicals and Potential Therapeutic Targets on Toxoplasma gondii Parasite.
Abdullahi SA; Unyah NZ; Nordin N; Basir R; Nasir WM; Alapid AA; Hassan Y; Mustapha T; Majid RA
Mini Rev Med Chem; 2020; 20(9):739-753. PubMed ID: 31660810
[TBL] [Abstract][Full Text] [Related]
36. Effect of Extracts of the Endemic Plants Centaurea lydia and Phlomis nissolii on Toxoplasma gondii.
Doğan Şığva ZÖ; Hasvatan EE; Gülen G; Uslu R; Eryıldız B; Durmuşkahya C; Kayalar H; Özbilgin A; Korkmaz M; Gündüz C
Turkiye Parazitol Derg; 2017 Sep; 41(3):164-168. PubMed ID: 29035246
[TBL] [Abstract][Full Text] [Related]
37. Anti-parasitic effect on Toxoplasma gondii induced by a spider peptide lycosin-I.
Tang Y; Hou S; Li X; Wu M; Ma B; Wang Z; Jiang J; Deng M; Duan Z; Tang X; Liu Y; Wang W; Han X; Jiang L
Exp Parasitol; 2019 Mar; 198():17-25. PubMed ID: 30682337
[TBL] [Abstract][Full Text] [Related]
38. Zinc oxide nanoparticles produced by Zingiber officinale ameliorates acute toxoplasmosis-induced pathological and biochemical alterations and reduced parasite burden in mice model.
El-Kady AM; S Hassan A; Mohamed K; Alfaifi MS; Elshazly H; Alamri ZZ; Wakid MH; Gattan HS; Altwaim SA; Al-Megrin WAI; Younis S
PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011447. PubMed ID: 37410712
[TBL] [Abstract][Full Text] [Related]
39. Auranofin inactivates Trichomonas vaginalis thioredoxin reductase and is effective against trichomonads in vitro and in vivo.
Hopper M; Yun JF; Zhou B; Le C; Kehoe K; Le R; Hill R; Jongeward G; Debnath A; Zhang L; Miyamoto Y; Eckmann L; Land KM; Wrischnik LA
Int J Antimicrob Agents; 2016 Dec; 48(6):690-694. PubMed ID: 27839893
[TBL] [Abstract][Full Text] [Related]
40. Anti-Toxoplasma activity of Sorghum bicolor-derived lipophilic fractions.
Abugri DA; Jaynes JM; Witola WH
BMC Res Notes; 2019 Oct; 12(1):688. PubMed ID: 31651353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
